Understand the source comparison
AHK-Cu Combined With Other Peptides: Comparison Table
Growth Hormone Secretagogues GHRP-2, Ipamorelin, Hexarelin None. Different receptor pathways High (9/10) Separate by 4–6 hours or use different sites Additive effects on tissue repair; GH upregulates systemic anabolism, AHK-Cu provides copper for collagen cros
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues
- GHRP-2, Ipamorelin, Hexarelin
- None. Different receptor pathways
- High (9/10)
- Separate by 4–6 hours or use different sites
- Additive effects on tissue repair; GH upregulates systemic anabolism, AHK-Cu provides copper for collagen crosslinking
- Mitochondrial Peptides
- MOTS-c, Humanin, SS-31
- None. Energy production vs structural repair
- Can be co-administered; no timing conflict
- Synergistic for recovery protocols; mitochondrial ATP supports collagen synthesis energy demands
- Tissue Repair Peptides
- BPC-157, TB-500
- Low. Complementary pathways (angiogenesis, migration vs collagen synthesis)
- High (8/10)
- Can be co-administered; rotate sites to avoid depot saturation
- Non-redundant repair mechanisms; BPC vascularisation + AHK-Cu matrix remodeling produces comprehensive tissue healing
- Copper-Binding Peptides
- GHK-Cu, other copper chelators
- Direct competition for copper ions
- Low (3/10)
- Avoid simultaneous use; separate by 12+ hours minimum
- Mechanistic redundancy; splitting copper between two chelators reduces efficacy of both
- Metal Chelators
- EDTA, DMSA, high-dose zinc
- Direct antagonism. Binds copper and prevents delivery
- Contraindicated (1/10)
- Do not combine in the same protocol
- Chelators render copper peptides inactive by sequestering the metal cofactor